zidovudine has been researched along with Uterine Hemorrhage in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyer, P; Cooper, E; Goldfarb, J; Hammill, H; Hodes, D; Jenson, H; Kovacs, A; LaRussa, P; McIntosh, K; Peavy, H; Pitt, J; Schluchter, M; Shearer, W; Sperling, R; Tuomala, R | 1 |
1 other study(ies) available for zidovudine and Uterine Hemorrhage
Article | Year |
---|---|
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cohort Studies; Cytomegalovirus; Female; Gestational Age; Herpesviridae Infections; Herpesvirus 4, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Oropharynx; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Urine; Uterine Hemorrhage; Virus Shedding; Zidovudine | 1998 |